[Experimental model of infection].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use; D002264:Carboxylic Acids / Q000627:therapeutic use; D004195:Disease Models, Animal; D004357:Drug Synergism; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D007166:Immunosuppressive Agents; D010406:Penicillins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy*; D051381:Rats; D013876:Thiophenes / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D005839:Gentamicins; D007166:Immunosuppressive Agents; D010406:Penicillins; D013876:Thiophenes; D002228:Carbenicillin
Das experimentelle Infektionsmodell.